Small GTPases and Their Role in Vascular Disease

Over eighty million people in the United States have cardiovascular disease that can affect the heart causing myocardial infarction; the carotid arteries causing stroke; and the lower extremities leading to amputation. The treatment for end-stage cardiovascular disease is surgical—either e...

Full description

Bibliographic Details
Main Authors: Alison Flentje, Richa Kalsi, Thomas S. Monahan
Format: Article
Language:English
Published: MDPI AG 2019-02-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/20/4/917
_version_ 1811336680410447872
author Alison Flentje
Richa Kalsi
Thomas S. Monahan
author_facet Alison Flentje
Richa Kalsi
Thomas S. Monahan
author_sort Alison Flentje
collection DOAJ
description Over eighty million people in the United States have cardiovascular disease that can affect the heart causing myocardial infarction; the carotid arteries causing stroke; and the lower extremities leading to amputation. The treatment for end-stage cardiovascular disease is surgical—either endovascular therapy with balloons and stents—or open reconstruction to reestablish blood flow. All interventions damage or destroy the protective inner lining of the blood vessel—the endothelium. An intact endothelium is essential to provide a protective; antithrombotic lining of a blood vessel. Currently; there are no agents used in the clinical setting that promote reendothelialization. This process requires migration of endothelial cells to the denuded vessel; proliferation of endothelial cells on the denuded vessel surface; and the reconstitution of the tight adherence junctions responsible for the formation of an impermeable surface. These processes are all regulated in part and are dependent on small GTPases. As important as the small GTPases are for reendothelialization, dysregulation of these molecules can result in various vascular pathologies including aneurysm formation, atherosclerosis, diabetes, angiogenesis, and hypertension. A better understanding of the role of small GTPases in endothelial cell migration is essential to the development for novel agents to treat vascular disease.
first_indexed 2024-04-13T17:44:01Z
format Article
id doaj.art-2496c503c34b48ba95b031d99d14408f
institution Directory Open Access Journal
issn 1422-0067
language English
last_indexed 2024-04-13T17:44:01Z
publishDate 2019-02-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-2496c503c34b48ba95b031d99d14408f2022-12-22T02:37:05ZengMDPI AGInternational Journal of Molecular Sciences1422-00672019-02-0120491710.3390/ijms20040917ijms20040917Small GTPases and Their Role in Vascular DiseaseAlison Flentje0Richa Kalsi1Thomas S. Monahan2Division of Vascular Surgery, Department of Surgery, University of Maryland School of Medicine, 22 South Greene Street, Suite S10B00, Baltimore, MD 21201, USADivision of Vascular Surgery, Department of Surgery, University of Maryland School of Medicine, 22 South Greene Street, Suite S10B00, Baltimore, MD 21201, USADivision of Vascular Surgery, Department of Surgery, University of Maryland School of Medicine, 22 South Greene Street, Suite S10B00, Baltimore, MD 21201, USAOver eighty million people in the United States have cardiovascular disease that can affect the heart causing myocardial infarction; the carotid arteries causing stroke; and the lower extremities leading to amputation. The treatment for end-stage cardiovascular disease is surgical—either endovascular therapy with balloons and stents—or open reconstruction to reestablish blood flow. All interventions damage or destroy the protective inner lining of the blood vessel—the endothelium. An intact endothelium is essential to provide a protective; antithrombotic lining of a blood vessel. Currently; there are no agents used in the clinical setting that promote reendothelialization. This process requires migration of endothelial cells to the denuded vessel; proliferation of endothelial cells on the denuded vessel surface; and the reconstitution of the tight adherence junctions responsible for the formation of an impermeable surface. These processes are all regulated in part and are dependent on small GTPases. As important as the small GTPases are for reendothelialization, dysregulation of these molecules can result in various vascular pathologies including aneurysm formation, atherosclerosis, diabetes, angiogenesis, and hypertension. A better understanding of the role of small GTPases in endothelial cell migration is essential to the development for novel agents to treat vascular disease.https://www.mdpi.com/1422-0067/20/4/917small GTPasescdc42rac1RhoAvascular endotheliumrestenosismigration
spellingShingle Alison Flentje
Richa Kalsi
Thomas S. Monahan
Small GTPases and Their Role in Vascular Disease
International Journal of Molecular Sciences
small GTPases
cdc42
rac1
RhoA
vascular endothelium
restenosis
migration
title Small GTPases and Their Role in Vascular Disease
title_full Small GTPases and Their Role in Vascular Disease
title_fullStr Small GTPases and Their Role in Vascular Disease
title_full_unstemmed Small GTPases and Their Role in Vascular Disease
title_short Small GTPases and Their Role in Vascular Disease
title_sort small gtpases and their role in vascular disease
topic small GTPases
cdc42
rac1
RhoA
vascular endothelium
restenosis
migration
url https://www.mdpi.com/1422-0067/20/4/917
work_keys_str_mv AT alisonflentje smallgtpasesandtheirroleinvasculardisease
AT richakalsi smallgtpasesandtheirroleinvasculardisease
AT thomassmonahan smallgtpasesandtheirroleinvasculardisease